BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 30
• 31

• Press Releases

  Osivax and GC Biopharma Enter Strategic Collaboration to Develop a Next-Generation Influenza Vaccine Combining OVX836 and GC FLU

  August 27, 2026

   · 

  5 min read
• Press Releases

  AlzeCure Pharma to Present at The Pareto Securities 17th Annual Healthcare Conference on September 2

  August 27, 2026

   · 

  1 min read
• Press Releases

  NYU Langone Health Names Sunil Rao, MD, Director of the Leon H. Charney Division of Cardiology and Welcomes Susheel Kodali, MD, to Lead Interventional Cardiology

  August 27, 2026

   · 

  7 min read
• Press Releases

  Biovica Expands Pharma Services Business with New Master Services Agreement

  August 27, 2026

   · 

  1 min read
• Press Releases

  Natera and Angiex Partner to Assess Response to Investigational Nuclear-Delivered Antibody-Drug Conjugate™ Using Signatera™

  August 27, 2026

   · 

  5 min read
• 

  Immunology and inflammation

  AstraZeneca, Amgen notch another late-stage win for Tezspire, this time in esophagitis

  AstraZeneca and Amgen co-develop and co-commercialize Tezspire under an April 2012 agreement. The partners are now planning another FDA submission for the asthma drug, which received an expansion into chronic rhinosinusitis last year.

  August 27, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Cancer

  RevMed could become ‘next oncology titan’ with Rasonque nod

  A future expansion of Rasonque into first-line pancreatic ductal adenocarcinoma could set Revolution Medicines up to hit $2.3 billion in sales by 2028, according to Truist Securities.

  August 27, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  Eton Pharmaceuticals to Participate at 2026 Wells Fargo Healthcare Conference

  August 27, 2026

   · 

  1 min read
• Press Releases

  Ainnocence Shows AINN-P1 Protein Foundation Model Improves Antibody-Antigen Affinity Ranking by 28% - From Sequence Alone

  Ainnocence’s foundation model trained from scratch, requiring no structure, no multiple sequence alignment, no fine-tuning, training in hours rather than weeks.

  August 27, 2026

   · 

  1 min read
• Press Releases

  HighLife Receives CE Mark Approval for Clarity Valve, the Next-Generation Valve for the HighLife TMVR System

  August 27, 2026

   · 

  6 min read